M Yokoyama, Y Izumiya, M Yoshizawa, R Usuda. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Chromans/adverse effectsCreatine Kinase/bloodDiabetes Mellitus, Type 2/drug therapyDrug Therapy, CombinationFemaleGlyburide/therapeutic useHumansHypoglycemic Agents/adverse effectsHypoglycemic Agents/therapeutic useIsoenzymesMiddle AgedRhabdomyolysis/chemically inducedThiazoles/adverse effectsThiazolidinedionesTroglitazone
Substances: See more » ChromansHypoglycemic AgentsIsoenzymesThiazolesThiazolidinedionesCreatine KinaseTroglitazoneGlyburide
Year: 2000 PMID: 10868879 DOI: 10.2337/diacare.23.3.421
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 19.112